Transfusion Medicine Reviews
Volume 22, Issue 3 , Pages 177-187, July 2008

Evidence for the Use of Recombinant Factor VIIa in the Prevention and Treatment of Bleeding in Patients Without Hemophilia

Departments of Transfusion Medicine, National Health Service Blood and Transplant, Bristol and Oxford, UK

Department of Haematology, North Bristol NHS Trust, UK

Department of Haematology, John Radcliffe Hospital, Oxford, UK

Intensive Care Unit, Derriford Hospital, Plymouth, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Acknowledgements of research support: National Health Service Blood & Transplant, UK.

PII: S0887-7963(08)00012-6

doi:10.1016/j.tmrv.2008.02.007

Transfusion Medicine Reviews
Volume 22, Issue 3 , Pages 177-187, July 2008

Article Tools